NovoCure
NVCR
NVCR
301 hedge funds and large institutions have $6.33B invested in NovoCure in 2022 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 94 increasing their positions, 103 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
19% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 43
27% less call options, than puts
Call options by funds: $76.8M | Put options by funds: $105M
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
301
Holding in Top 10
2
Calls
$76.8M
Puts
$105M
Top Buyers
| 1 | +$220M | |
| 2 | +$81M | |
| 3 | +$25.5M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.81M |
| 5 |
Bank of New York Mellon
New York
|
+$5.92M |
Top Sellers
| 1 | -$58M | |
| 2 | -$26.7M | |
| 3 | -$20.7M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$15.4M |
| 5 |
Two Sigma Investments
New York
|
-$9.29M |